Bengal: 2,000 Bottles Of Phensedyl Cough Syrup Seized, Three Arrested

Krishnanagar :  (PTI) Around 2,000 bottles of banned cough syrup Phensedyl were seized and three people were arrested on Tuesday in West Bengal’s Nadia district which borders Bangladesh, police said.

Acting on a tip-off, police intercepted two vehicles in Natunpara in Bhimpur police station area and seized the cough syrup bottles, while arresting the occupants, a police officer said.

The arrested persons are residents of Nadia’s Karimpur, which is close to the India-Bangladesh border.

Phensedyl contains codeine, which is a narcotic drug that causes addiction when used in large quantities over a period of time. The cough syrup is used as an intoxicant in Bangladesh as an alternative to alcohol.

Related Posts

  • Pharma
  • May 14, 2025
  • 82 views
DTAB asks DCGI to take up withdrawal of license for certain FDC antibiotics with SLAs

The Drugs Technical Advisory Board (DTAB) has directed the Central drug regulator to take up the matter related to withdrawal of product license for antibiotic fixed dose combinations (FDCs), which…

  • Pharma
  • May 14, 2025
  • 91 views
India’s anti-obesity drug market quadruples in five years on lifestyle disease surge

India’s anti-obesity drug market has grown more than fourfold in the last five years fuelled by rising instances of lifestyle diseases along with greater affordability and willingness among a section…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

DTAB asks DCGI to take up withdrawal of license for certain FDC antibiotics with SLAs

DTAB asks DCGI to take up withdrawal of license for certain FDC antibiotics with SLAs

India’s anti-obesity drug market quadruples in five years on lifestyle disease surge

India’s anti-obesity drug market quadruples in five years on lifestyle disease surge

3 held with 60,000 tramadol tablets

3 held with 60,000 tramadol tablets

Indian Pharma May See Limited Short-Term Impact from US Drug Pricing Order

Indian Pharma May See Limited Short-Term Impact from US Drug Pricing Order